KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adaptive Biotechnologies (ADPT) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for Adaptive Biotechnologies (ADPT) over the last 7 years, with Q3 2025 value amounting to 0.51.

  • Adaptive Biotechnologies' Asset Utilization Ratio rose 6511.91% to 0.51 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.51, marking a year-over-year increase of 6511.91%. This contributed to the annual value of 0.3 for FY2024, which is 3287.09% up from last year.
  • According to the latest figures from Q3 2025, Adaptive Biotechnologies' Asset Utilization Ratio is 0.51, which was up 6511.91% from 0.41 recorded in Q2 2025.
  • In the past 5 years, Adaptive Biotechnologies' Asset Utilization Ratio ranged from a high of 0.51 in Q3 2025 and a low of 0.11 during Q1 2021
  • Over the past 5 years, Adaptive Biotechnologies' median Asset Utilization Ratio value was 0.2 (recorded in 2022), while the average stood at 0.24.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 8111.43% in 2021, then plummeted by 1207.49% in 2023.
  • Over the past 5 years, Adaptive Biotechnologies' Asset Utilization Ratio (Quarter) stood at 0.16 in 2021, then surged by 32.14% to 0.21 in 2022, then fell by 12.07% to 0.19 in 2023, then surged by 74.16% to 0.33 in 2024, then soared by 57.06% to 0.51 in 2025.
  • Its Asset Utilization Ratio was 0.51 in Q3 2025, compared to 0.41 in Q2 2025 and 0.36 in Q1 2025.